Abstract
Aims: To study the sociodemographic characteristics and sexual behaviours in contraception choices of injecting drug users (IDUs) and to compare the contraceptive practices of non-HIV-positive IDUs to those of the general population. Design: Two surveys were used: a sample of IDUs attending 10 drug abuse treatment centres in the Paris region (IDU) and the Parisian subsample of the National French Survey of Sexual Behaviour (ACSF). Measurements: Percentages of contraception practices were estimated separately for 81 IDU and 130 ACSF women, and for 175 IDU and 168 ACSF men, aged 25–34, not reporting prostitution or HIV seropositivity. Findings: Most IDU (77%) and ACSF (84%) women, and IDU (73%) and ACSF (75%) men currently used a contraceptive method. Male condoms were more widely used by IDUs than by the general population (64 vs. 10% in women, 75 vs. 14% in men), for all subgroups of educational level, marital status, recent multipartnership status and sexual activity. Conclusions: Contraceptives are used as often by IDUs as by the general population aged 25–34. However, the methods employed differ, with higher condom use by IDUs, which suggest that IDUs take into account the risk of HIV contamination in their contraceptive practices.
References
Cates W Jr. Contraception, unintended pregnancies, and sexually transmitted diseases: Why isn't a simple solution possible? Am J Epidemiol 1996; 143(4): 311–318.
Cates W Jr, Stone KM. Family planning, sexually transmitted diseases and contraceptive choice: A literature update - Part I [see comments]. Fam Plann Perspect 1992; 24(2): 75–84.
Fraser AC. Drug addiction in pregnancy. Lancet 1976; 2(7991): 896–899.
Donoghoe MC. Sex, HIV and the injecting drug user. Br J Addict 1992; 87(3): 405–416.
Vidal-Trecan G, Coste J, Varescon-Pousson I, Reboul-Marty J, Christoforov B, Boissonnas A. Patterns of sexual and injecting risk behaviours in French intravenous drug users not reporting HIV and hepatitis C virus seropositivities. Addiction 1998; 93(11): 1657–1668.
Ralph N, Spigner C. Contraceptive practices among female heroin addicts. Am J Public Health 1986; 76(8): 1016–1017.
Murphy D, Lynch M, Desmond N, Mulcahy FM. Contraceptive practices in HIV seropositive females in Ireland. Int J STD AIDS 1993; 4(2): 107–109.
Baqi S, Nabi N, Hasan SN, et al. HIV antibody seroprevalence and associated risk factors in sex workers, drug users, and prisoners in Sindh, Pakistan. J Acq Imm Def Synd Human Retrovirol 1998; 18(1): 73–79.
Watters JK. Trends in risk behavior and HIV seroprevalence in heterosexual injection drug users in San Francisco, 1986-1992. J Acq imm Def Synd 1994; 7(12): 1276–1281.
Boissonnas A, Vidal-Trecan G, Coste J, Varescon-Pousson I, Reboul-Marty J. Les Comportements à Risque des Toxicomanes [Intravenous Drug Users Risk Behaviours]. Sèvres: Editions médicales et scientifiques EDK, 1996: 95pp.
Spira A, Bajos N, le groupe ACSF. Les Comportements Sexuels en France [Sexual Behaviors in France]. Paris: Collection des rapports officiels; La documentation française, 1993: 351pp.
Warszawski J, Messiah A, Lellouch J, Meyer L, Deville JC. Estimating means and percentages in a complex sampling survey: Application to a French national survey on sexual behaviour (ACSF). Analyse des Comportements Sexuels en France. Stat Med 1997; 16(4): 397–423.
Fu H, Darroch JE, Haas T, Ranjit N. Contraceptive failure rates: New estimates from the 1995 National Survey of Family Growth. Fam Plann Perspect 1999; 31(2): 56–63.
Oddens BJ. Determinants of contraceptive use among women of reproductive age in Great Britain and Germany. II: Psychological factors. J Biosoc Sci 1997; 29(4): 437–470.
Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: Risk-factor analysis. Lancet 2001; 357(9266): 1397–1401.
Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996; 86(5): 655–661.
Calsyn DA, Saxon AJ, Freeman G Jr, Whittaker S. Ineffectiveness of AIDS education and HIV antibody testing in reducing high-risk behaviors among injection drug users. Am J Public Health 1992; 82(4): 573–575.
Kamb ML, Fishbein M, Douglas JM Jr, Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: A randomized controlled trial. Project RESPECT Study Group. JAMA 1998; 280(13): 1161–1167.
Kenen RH, Armstrong K. The why, when and whether of condom use among female and male drug users. J Commun Health 1992; 17(5): 303–317.
Ross MW. Attitudes toward condoms and condom use: A review. Int J STD AIDS 1992; 3(1): 10–16.
Cushman LF, Romero D, Kalmuss D, Davidson AR, Heartwell S, Rulin M. Condom use among women choosing long-term hormonal contraception. Fam Plann Perspect 1998; 30(5): 240–243.
Messiah A, Dart T, Spencer BE, Warszawski J. Condom breakage and slippage during heterosexual intercourse: A French national survey. French National Survey on Sexual Behavior Group (ACSF). Am J Public Health 1997; 87(3): 421–424.
Darke S, Hall W, Heather N, Ward J, Wodak A. The reliability and validity of a scale to measure HIV risktaking behaviour among intravenous drug users. AIDS 1991; 5(2): 181–185.
McElrath K, Chitwood DD, Griffin DK, Comerford M. The consistency of self-reported HIV risk behavior among injection drug users. Am J Public Health 1994; 84(12): 1965–1970.
Latkin CA, Vlahov D, Anthony JC. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction 1993; 88(4): 517–526.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vidal-Trecan, G., Warszawski, J., Coste, J. et al. Contraceptive practices of non-HIV-seropositive injecting drug users. Eur J Epidemiol 18, 863–869 (2003). https://doi.org/10.1023/A:1025643421939
Issue Date:
DOI: https://doi.org/10.1023/A:1025643421939